Psychosexual Morbidity in Women With Ovarian Cancer: Evaluation by Germline BRCA Gene Mutational Status

Psychosexual Morbidity in Women With Ovarian Cancer: Evaluation by Germline BRCA Gene Mutational Status

ABSTRACT: Introduction: Up to 75% of women with ovarian cancer experience psychosexual morbidity and approximately 15–20% of women with ovarian cancer have a germline BRCA1/2 mutation (gBRCAm). However, psychosexual morbidity remains unexplored in women with gBRCAm ovarian cancer. Aim: Given their...

Full description

Bibliographic Details
Main Authors: Chloe A. Logue, MBChB, MRes, Julia Pugh, BNurs (hons), MSc, PGDip, Philip Foden, BSc, MSc, Reem D. Mahmood, MBChB, MRCP, Robert D. Morgan, MBBS, Claire Mitchell, MBBS, MRCP, PhD, Jurjees Hasan, MSc, MD, FRCP, Andrew R. Clamp, MA, BMBCh, PhD, Gordon C. Jayson, PhD, FRCP
Format: Article
Language:English
Published: Oxford University Press 2022-02-01
Series:Sexual Medicine
Subjects:
Ovar*
BRCA
Psychosex*
Menopaus*
Online Access:http://www.sciencedirect.com/science/article/pii/S2050116121001458

Internet

http://www.sciencedirect.com/science/article/pii/S2050116121001458

Similar Items